(C): instagram-willallwailam
The heart bleeds with pain for the ardent followers of this Hong Kong actor Will Or Wai-Lam who is popularly known for the 2021 breakthrough movie of his ‘Drifting’. He has been building his career in acting and Will has agreed to debut his first stage play titled ‘Let Me Entertain You’ which is scheduled for the premier on 8 August. Unfortunately he is diagnosed with the four stage of lung cancer. Amidst this challenging days, Will with his strong will continuing his rehearsals with an optimistic approach and not breaking down with fear.
“At 33, the prime of my life, I’m forced to rest. Don’t worry, I’ll be fine… I’m used to playing against the odds.” said the actor Will.
His words resonate a man with profound love and dedication for his profession which would definitely make a soul stronger in a terrific situations. He has now decided to opt for a targeted therapy, a kind of treatment in which certain drugs or substances will be utilised for medication to identify and attack the specified cancer cells. And the actor has requested the media for space for his priority.
Read More: HYBE CINE FEST Debuts in Hong Kong and K-Pop Stars Taking Over the Big Screen!
The BAFTA 2026 nominations have officially been unveiled, setting the stage for a dramatic awards season. Paul Thomas Anderson has…
The M7 World Championship has officially rewritten esports history, establishing itself as the most-watched mobile esports event of all time.…
Netflix continues to solidify its commitment to Southeast Asian storytelling with the announcement of a high-octane ASEAN crime drama. This…
Fusion street food from Thailand and Malaysia dominates 2026 culinary rankings, blending bold regional flavors with global twists. Thai-Malay fusion…
On January 26, 2026, at the Nustar Hotel in Cebu City, Philippines, the 63 rd ASEAN National Tourism Organizations Meeting…
Clawdbot, the viral open-source AI agent, promises powerful automation but sparks major security concerns for businesses. This local-first assistant was…
This website uses cookies.
Read More